ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NCT:NCT06608823 · RECRUITING
广告
NCT编号NCT06608823
状态RECRUITING
开始日期2025-06-18
SponsorJenaValve Technology, Inc. (INDUSTRY)
First posted
Last updated
简要摘要
To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。